| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |